The Hypotension drugs in development market research report provides comprehensive information on the therapeutics under development for Hypotension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Hypotension. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Hypotension and features dormant and discontinued products.
GlobalData tracks nine drugs in development for Hypotension by nine companies/universities/institutes. The top development phase for Hypotension is preclinical with four drugs in that stage. The Hypotension pipeline has eight drugs in development by companies and one by universities/ institutes. Some of the companies in the Hypotension pipeline products market are: La Jolla Pharmaceutical, Amneal Pharmaceuticals and PharmaIN.
The key targets in the Hypotension pipeline products market include Vasopressin V1a Receptor, Vasopressin V1b Receptor, and Vasopressin V2 Receptor.
The key mechanisms of action in the Hypotension pipeline product include Vasopressin V1a Receptor Agonist with two drugs in Phase III. The Hypotension pipeline products include four routes of administration with the top ROA being Oral and three key molecule types in the Hypotension pipeline products market including Small Molecule, and Synthetic Peptide.
Hypotension overview
Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness, and weakness. Treatment is required for patients with signs and symptoms.
For a complete picture of Hypotension’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
